Back
Blueprint Medicines Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
62
BPMC
Blueprint Medicines
Last Price:
105.64
Seasonality Move:
10.8%
Buy
64
NBY
NovaBay Pharmaceuticals
Last Price:
3.45
Seasonality Move:
0.61%
Buy
62
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $106.36. The Score for BPMC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- BPMC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $3.65. The Score for NBY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- NBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $106.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $3.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.
BPMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.85 | Buy |
| Relative Strength Index (14 RSI): | 60.79 | Buy |
| Chaikin Money Flow: | 558021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (97.31 - 108.53) | Buy |
| Bollinger Bands (100): | (81.73 - 99.95) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 47.13 | Sell |
| Chaikin Money Flow: | -280811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-0.44 - 0.94) | Buy |
| Bollinger Bands (100): | (-0.19 - 0.51) | Buy |
BPMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.13 | Buy |
| 20-day SMA: | 105.5 | Buy |
| 50-day SMA: | 96.67 | Buy |
| 200-day SMA: | 75.89 | Buy |
| 8-day EMA: | 103.6 | Buy |
| 20-day EMA: | 102.69 | Buy |
| 50-day EMA: | 97.98 | Buy |
| 200-day EMA: | 81.23 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.29 | Buy |
| 50-day SMA: | 0.17 | Buy |
| 200-day SMA: | 0.28 | Buy |
| 8-day EMA: | 0.92 | Buy |
| 20-day EMA: | 0.46 | Buy |
| 50-day EMA: | 0.26 | Buy |
| 200-day EMA: | 0.51 | Buy |
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Blueprint Medicines Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||